Ketamine Clinical Trials
58 recruitingDrug
Phase 221Phase 414Phase 111Not Applicable5Phase 35Early Phase 13
Showing 1–20 of 58 trials
Recruiting
Early Phase 1
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Major Depressive Disorder
Emory University140 enrolled1 locationNCT05327699
Recruiting
Early Phase 1
Ketamine and Propofol NeuroImaging
PainAnesthesia
Keith M Vogt60 enrolled1 locationNCT07294092
Recruiting
Phase 2
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Depressive DisorderPost Traumatic Stress DisorderSuicidal Ideation+2 more
Yale University30 enrolled1 locationNCT05786066
Recruiting
Phase 1
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Post Traumatic Stress DisorderDepressive Disorder, Major
Yale University50 enrolled1 locationNCT05915013
Recruiting
Early Phase 1
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Pancreatic CancerAnxiety
Cedars-Sinai Medical Center20 enrolled1 locationNCT05086250
Recruiting
Phase 1Phase 2
Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients
Haemodynamic Rebound
New Valley University2 enrolled1 locationNCT06490731
Recruiting
Phase 2
Ketamine Alcohol (in Treatment-Resistant Depression)
Magnetic Resonance ImagingAlcoholismMajor Depression
Mark Niciu60 enrolled1 locationNCT02122562
Recruiting
Anesthetics and Analgesics in Children
PainAnesthesia
Chi Dang Hornik500 enrolled13 locationsNCT03427736
Recruiting
Phase 1
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
DepressionHealthy VolunteerMajor Depressive Disorder
National Institute of Mental Health (NIMH)150 enrolled1 locationNCT03065335
Recruiting
Phase 1
Understanding Ketamine's Dissociative Effects (KD Study)
Epilepsy
Stanford University20 enrolled1 locationNCT04861051
Recruiting
Phase 2
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Obsessive-Compulsive Disorder
Stanford University150 enrolled1 locationNCT05940324
Recruiting
Phase 1
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
DepressionSuicideSuicidal Ideation
Lindsay Maguire, MD50 enrolled2 locationsNCT06085937
Recruiting
Phase 2
Ketamine for Veterans With Parkinson's Disease
Parkinson's Disease
VA Office of Research and Development80 enrolled1 locationNCT06231563
Recruiting
Phase 4
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
Hemorrhoids
University of Oklahoma100 enrolled1 locationNCT04248205
Recruiting
Phase 4
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Opioid UsePostoperative PainDepression+2 more
Texas Tech University Health Sciences Center90 enrolled2 locationsNCT06903819
Recruiting
Not Applicable
ACT_for Alcohol Use Disorder and Depression
Depression - Major Depressive DisorderAlcohol Use Disorder
Centre hospitalier de l'Université de Montréal (CHUM)30 enrolled1 locationNCT06620276
Recruiting
University of Iowa Interventional Psychiatry Service Patient Registry
Major Depressive DisorderMajor DepressionObsessive-Compulsive Disorder+4 more
Mark Niciu1,000 enrolled1 locationNCT04480918
Recruiting
Phase 1
Investigation of Psychedelic Effects in Psychoactive Substances
Psychedelic Effects in Healthy Volunteers
Johns Hopkins University50 enrolled1 locationNCT06772753
Recruiting
Phase 3
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
Chronic Daily Headache
University Health Network, Toronto56 enrolled2 locationsNCT05306899
Recruiting
Phase 1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
HealthyMajor Depressive DisorderTreatment Resistant Depression
Baylor College of Medicine100 enrolled2 locationsNCT06480201